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Abstract: Membrane transport systems participate in fundamental activities such as cell 
cycle control, proliferation, survival, volume regulation, pH maintenance and regulation of 
extracellular matrix synthesis. Multiple isoforms of Na
+, K
+-ATPase are expressed in 
primary chondrocytes. Some of these isoforms have previously been reported to be 
expressed exclusively in electrically excitable cells (i.e., cardiomyocytes and neurons). 
Studying the distribution of Na
+, K
+-ATPase isoforms in chondrocytes makes it possible to 
document the diversity of isozyme pairing and to clarify issues concerning Na
+, K
+-ATPase 
isoform abundance and the physiological relevance of their expression. In this study, we 
investigated the expression of Na
+, K
+-ATPase in a human chondrocyte cell line (C-20/A4) 
using a combination of immunological and biochemical techniques. A panel of   
well-characterized antibodies revealed abundant expression of the α1, β1 and β2 isoforms. 
Western blot analysis of plasma membranes confirmed the above findings. Na
+, K
+-ATPase 
consists of multiple isozyme variants that endow chondrocytes with additional homeostatic 
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control capabilities. In terms of Na
+, K
+-ATPase expression, the C-20/A4 cell line is 
phenotypically similar to primary and in situ chondrocytes. However, unlike freshly 
isolated chondrocytes, C-20/A4 cells are an easily accessible and convenient in vitro model 
for the study of Na
+, K
+-ATPase expression and regulation in chondrocytes. 
Keywords: Na
+, K
+-ATPase; subunit; isoform; isozyme; chondrocyte; cell line; C-20/A4; 
western blotting; immunofluorescence; FACS analysis 
 
1. Introduction 
Chondrocytes are specialized resident cells of articular cartilage responsible for the maintenance 
and turnover of highly charged extracellular matrix (ECM) macromolecules that endow cartilage with 
its unique load bearing properties [1,2]. Chondrocytes must survive in an unusual ionic and osmotic 
environment that makes the maintenance of intracellular [Na
+], [K
+] and pH a high priority if the 
physiological turnover of cartilage matrix is to be accomplished [3]. Membrane transport in cartilage 
has remained relatively unexplored compared to other cells types. However, over the last decade we 
have witnessed increasing progress in research aimed at identifying and characterizing ion 
channels [4], nutrient transporters [5,6] and other types of membrane transporters [3] in chondrocytes. 
The importance of expanded research into ion and metabolite transport in chondrocytes from normal 
and degenerate articular cartilage is essential to understanding and dealing with pathophysiological 
changes that occur in joint disorders such as arthritis. Membrane transport systems regulate cell 
shape  [7], cell volume  [8], intracellular pH  [9], intracellular signaling  [10] and transepithelial 
transport  [11]. In chondrocytes the extracellular ionic and osmotic environment also regulates the 
synthesis of extracellular matrix macromolecules [3]. The mechanical performance of cartilage relies 
on the biochemical properties of matrix macromolecules and any alterations to the ionic and osmotic 
extracellular environment of chondrocytes in turn influence the volume, intracellular pH and ionic 
content of the cells [12]. These changes in turn modify the synthesis and degradation of extracellular 
matrix macromolecules [13]. Physiological ion homeostasis is fundamental to the routine functioning 
of cartilage and the factors that control the integrity of this highly evolved and specialized tissue. 
Therefore, membrane transporters may prove suitable therapeutic targets in treating joint disorders in 
the future. 
Na
+, K
+-ATPase is an important regulator of intracellular electrolyte levels in most mammalian 
cells [14]. It is a Mg
2+-dependent transport pump responsible for maintaining the low intracellular  
Na
+:K
+ ratio that is essential for cell homeostasis and physiological function. It catalyzes the active 
uptake of K
+ and extrusion of Na
+ at the expense of hydrolyzing ATP with a stoichiometry of 3 Na
+ 
for 2 K
+. The active form of Na
+, K
+-ATPase is an integral membrane protein complex composed of 
three non-covalently attached subunits; a 110 kDa catalytic α subunit, a 45–55 kDa glycosylated β 
subunit and a 10 kDa proteolipid γ subunit [15,16]. Four α isoforms encoded by different genes have 
been identified which are ~85% identical at the protein level [17–19]. The β subunit also exists as four 
isoforms; three isoforms belong to Na
+, K
+-ATPase [20–22]. The fourth β isoform, β4, may function as Int. J. Mol. Sci. 2012, 13 5021 
 
 
an interchangeable component of the Na
+, K
+-ATPase and the non-gastric P-type H
+, K
+-ATPase but 
only in skeletal and cardiac muscle [23,24]. 
Differences in kinetic properties between Na
+, K
+-ATPase α isoforms have implications for Na
+ and 
K
+ transport rates and hence for Na
+ dependent uptake of nutrients including amino acids, sugars and 
other vital nutrients  [14]. The α subunit isoforms have shown significantly different affinities for   
Na
+, K
+, ATP and ouabain when expressed in HeLa cells and sf-9 insect cells (for a review see [14]).  
In addition the β isoforms alter the ion affinity of individual α subunits in α-β complexes [15]. 
Earlier work in our laboratories has revealed that primary and in situ chondrocytes abundantly 
express Na
+, K
+-ATPase (1.75 × 10
5 sites per chondrocyte; [25,26]). Expression of Na
+, K
+-ATPase is 
sensitive to the extracellular ionic and osmotic environment within the extracellular matrix and   
in vitro [27,28]. We have also shown that Na
+, K
+-ATPase exists as multiple isozyme variants in 
bovine cartilage [25] and human cartilage [29]. The expression of three α (α1, α2, α3) and three β  
(β1, β2, β3) subunit isoforms in human cartilage indicates that up to nine different isozymes could be 
formed in this tissue [29]. Existence of multiple Na
+, K
+-ATPase isozymes implies the requirement for 
a finely tuned but varied ‘sodium pump’ for the specialized handling of transmembrane cation 
gradients. The aim of this study was to investigate the expression of Na
+, K
+-ATPase in a human 
chondrocyte cell line (C-20/A4) using a panel of well-characterized antibodies and a combination of 
immunological and biochemical techniques. 
2. Results and Discussion 
2.1. Characterization of the α Isoform Specific Antibodies 
Selected antibodies against the α1, α2 and α3 isoforms (α6F, McB2 and XVIF9G10 monoclonal 
antibodies) were characterized by western blotting to confirm their cross-reactivity with their 
respective protein targets in human brain and skeletal muscle (Figure 1). 
Figure 1. Western blots showing expression of Na
+, K
+-ATPase α subunit isoforms in 
human brain and skeletal muscle (positive control tissues); α1, α2 and α3 (112 kDa). + or − 
refer to samples being heated or not heated before electrophoresis. The data presented 
confirms that the α6F, McB2 and XVIF9G10 monoclonal antibodies recognize their target 
isoforms (α1, α2 and α3, respectively) in human brain and skeletal muscle. 
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2.2. Western Blotting of α and β Isoforms in C-20/A4 Cells 
The expression of Na
+, K
+-ATPase isoforms in plasma membrane enriched microsomes of   
C-20/A4 cells was investigated by western blotting. Membrane proteins were separated by SDS-PAGE 
in 4–12% NuPAGE gradient gels (Figure 2A). Membrane proteins were then blotted onto 
nitrocellulose membranes and blots incubated with isoform specific antibodies. Western blot analysis 
clearly established the presence of α1, α3, β1 and β2. Antibodies to α1 and α3 satisfactorily cross-reacted 
with protein bands between the 97.4 and 116 kDa markers (Figure 2B). As expected, the ubiquitous  
α1 isoform was found in higher quantities compared to α3 on the alkaline phosphatase-conjugated 
antibody-probed membranes. However, there was no evidence for α2 expression in chondrocytes. The 
western blots produced detectable bands within 10–15 min suggesting a low abundance of plasma 
membrane Na
+, K
+-ATPase in chondrocyte-like cells. The high specificity of the antibodies for   
their respective antigens in brain homogenates has previously been demonstrated using western 
blotting [25,26,30]. Due to the lack of specific antibodies to human α4 and β3, the expression of these 
isoforms was not investigated at the protein level. 
Figure 2. (a) Electrophoretic separation of human chondrocyte microsomes using 
Coomassie blue stained NuPAGE polyacrylamide gel. Molecular weight markers are 
shown in kDa (lane M) together with human chondrocyte plasma membrane enriched 
microsomal fractions (lanes 1 and 2). Lane 3 is a representative densitometric scan of the 
membrane proteins resolved in lane 2 and shows that most of the membrane proteins 
expressed in human chondrocyte-like cells are between 30 and 200 kDa markers with large 
aggregate peaks around 200, 95, 68 and 50 kDa. (b) Western blots showing expression of 
Na
+, K
+-ATPase isoforms in human chondrocyte-like cells; α1 and α3 (110 kDa), β1 and 
β2 (55 kDa) and the absence of α2. (c) FACS analysis of chondrocytes immunostained 
with monoclonal antibodies to the α subunit of Na
+, K
+-ATPase. In each panel the density 
plot on the left shows the size distribution of the cells analyzed and the histogram on the 
right shows the FITC positive cells as a frequency distribution. The highest FITC staining 
was observed with the α1 specific antibody followed by the pan α antibody. The lowest 
staining was observed with the non-immune control anti-mouse IgG followed by α2 and α3 
specific antibodies. 
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Figure 2. Cont. 
(c) 
2.3. FACS Analysis 
FACS analysis demonstrated a relatively high level of α1 expression (67% positive cells) compared to 
α2 and α3 (1.14% and 5.28%, respectively; Table 1) in human chondrocyte-like cells. Autofluorescence 
was negligible, as was binding of non-immune mouse serum (Figure 2C). Expression levels of β1 and β2 
isoforms were also found to be relatively high in these cells (79.49% and 87.19% respectively; see 
Table 1). Overall, the immunohistochemical, immunofluorescence, FACS and Western blot results 
presented in this paper suggest that although the α1, β1 and β2 isoforms are the most abundant isoform 
proteins expressed, lower, but nevertheless detectable levels of α3 protein present in human 
chondrocyte-like cells. Int. J. Mol. Sci. 2012, 13 5024 
 
 
Table 1. Quantitative analysis of Na
+, K
+-ATPase isoform distribution in C-20/A4 cells. 
Chondrocytes immunostained using α subunit specific antibodies and secondary   
FITC-conjugated anti-mouse IgG were examined by FACScan and the data analyzed using 
WinMDI 2.8 flow cytometry software [31]. 
Antigen 
Number of Cells 
Counted 
Number of FITC 
Positive Cells 
% FITC 
Labeling 
Mean Fluorescence 
Intensity 
α1 6800  4568  67.18  19.2 
α2 3963  45  1.14  16.5 
α3 5904  312  5.28  16.1 
1 195  155  79.49  36.18 
2 3287  2866  87.19  45.83 
2.4. Immunofluorescence and Immunocytochemistry  
Immunocytochemical staining confirmed the presence of α1 and lower levels of α3 (Figures 3 and 4). 
The α1 isoform was found in abundance as expected; the monoclonal antibodies α620 and α6F, which 
had both reacted strongly on Western blots, also worked well in immunofluorescence experiments. The 
β1 and β2 subunit isoforms were also detected in roughly equal proportions (Figures 3 and 4). 
Immunoreactive cells exhibited strong alkaline phosphatase staining when probed with the pan α 
monoclonal antibody (mAb 9A7) and the α1 specific antibody; no α2 staining was observed but the α3 
antibodies produced some immunostaining (Figures 3 and 4). Conventional immunofluorescence 
micrographs revealed strong expression of α1 on the plasma membrane. The pan α monoclonal 
antibody (mAb 9A7) produced the most intense immunofluorescence staining possibly due to the 
combined signal from α1 and α3 isoforms (Figure 3). 
Figure 3. Indirect immunofluorescence localization of α and β isoforms of Na
+, K
+-ATPase 
in human chondrocyte-like cells attached to poly-L-lysine coated slides. Cells were probed 
with α and β isoform specific antibodies and secondary Fluorescein-conjugated IgG. Nuclei 
were counterstained red with propidium iodide. Bar indicates 10 μm. 
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Figure 4. Immunohistochemical detection of Na
+, K
+-ATPase  α isoforms in human 
chondrocytes using alkaline phosphatase-labeled anti-mouse and anti-rabbit secondary 
antibodies. Detection was by Fast Red TR/Napthol AS-MX phosphate   
(4-chloro-2-methylbenzenediazonium/3-Hydroxy-2-naphtoic acid 2,4-dimethylanilide 
phosphate). The following antibodies were used: pan α antibody, α1 (α 6F) antibody,   
α2 (McB2) antibody and α3 (XVIF9G10) antibody. Original magnifications in each   
panel × 400. Bar indicates 10 μm. 
 
 
Recent studies of isolated bovine chondrocytes in our laboratory have revealed a high plasma 
membrane Na
+, K
+-ATPase density for these relatively small cells  [25]. In addition to plasma 
membrane Na
+, K
+-ATPase, a large component is localized in intracellular membranes [32]. In bovine 
cartilage, the density of Na
+, K
+-ATPase correlates with matrix glycosaminoglycan concentrations and 
hence with tissue Na
+ [27] suggesting a feedback mechanism for the regulation of Na
+, K
+-ATPase 
abundance by matrix proteoglycans. Molecular studies in bovine chondrocytes have revealed two α 
(α1 and α3) and two β (β1 and β2) Na
+, K
+-ATPase isoforms [25]. These early studies suffered from a 
number of limitations. First, they were completed before the cloning and identification of the α4 and 
β3 isoforms. Second, some of the antibodies used in the early studies were obtained from commercial 
sources and consequently were not sufficiently well characterized. Recent studies of Na
+, K
+-ATPase 
isoform expression in articular chondrocytes in human cartilage explants have resulted in a more 
consistent, but significantly more complicated description of isoform composition; 3 α (α1, α2 and α3) 
and 2 β isoforms (β1 and β2) are expressed in addition to several other key Na
+ dependent transport 
systems [29,33]. 
The evidence for α3 expression in cartilage has gained considerable support since it was first 
proposed [25,26]. The well-characterized α3 specific monoclonal antibody XVIF9-G10 has been used 
successfully to demonstrate α3 expression in brain and heart [30] and articular cartilage [25,26,29]. 
Another well-characterized monoclonal antibody, McBX3, has been used successfully to demonstrate 
α3 expression in human articular cartilage  [29]. There is evidence that the α3 subunit is   Int. J. Mol. Sci. 2012, 13 5026 
 
 
post-translationally modified at the site of McBX3 binding in several tissues and this modification 
abolishes the affinity of McBX3 for its unique epitope on the α3 protein [34]. The fact that McBX3 is 
able to bind α3 in cartilage clearly validates that the α3 isoform expressed in cartilage is similar to the 
neuronal α3 isoform [29]. 
The expression of α3 may be related to the unusual ionic environment of chondrocytes [3]. In terms 
of their affinity for Na
+, the α isoforms exhibit significantly different kinetic properties; the affinity of 
α3 for intracellular Na
+ is orders of magnitude lower than α1 isoform (reviewed in [14,15]). It is 
therefore possible that chondrocyte Na
+, K
+-ATPase isozymes containing α3 subunits fulfill the vital 
physiological function of controlling intracellular Na
+ during joint loading or other scenarios in which 
rapid changes occur to the intracellular Na
+:K
+ ratio [3]. Recent observations in isolated chondrocytes 
suggest that the α3 subunit may be preferentially upregulated along with the α1 subunit following 
long-term changes in extracellular Na
+ resulting in steeper transmembrane Na
+ gradients [32]. Chronic 
exposure of chondrocytes to high extracellular Na
+ results in accumulation of α1 and α3 isoforms on 
the plasma membrane of chondrocytes and also in subcellular compartments [28]. Thus α3 with its low 
affinity for Na
+ working in parallel with α1 isoform may allow chondrocytes to respond more 
effectively to physiological changes in intracellular Na
+ that occur in vivo under load. Furthermore, the 
high affinity of α3 for ouabain raises the possibility of independent regulation of Na
+, K
+-ATPase 
isozymes by endogenous ouabain-like compounds. 
The apparent lack of α2 expression in human chondrocyte-like cells is worthy of further discussion. 
Studies on isolated bovine articular chondrocytes have confirmed the absence of α2 expression [25,26]. 
Indeed, the predominant α isoforms expressed in isolated chondrocytes are α1 and α3, although α1 
appears to be more abundant than α3 [25,26]. However, bovine and human articular chondrocytes  
in situ appear to express the α2 isoform [25,26,29]. The observation that α2 immunoreactivity is lost in 
isolated cells suggests that expression of this isoform is under hormonal regulation in cartilage.   
The lack of α2 in human chondrocyte-like cells supports this notion. In adipocytes (close relatives of 
chondrocytes) the α2 isoform is highly insulin sensitive in terms of its expression, regulation, function 
and cell surface recruitment [35,36]. It is possible that expression of α2 and possibly also other α 
isoforms is under hormonal control by insulin or IGF-1 (insulin like growth factor), a dominant 
anabolic mediator in cartilage. 
The existence and variability of β isoforms in human chondrocytes also raises important issues that 
need to be addressed. Abundant expression of β1 in chondrocytes is not surprising given its ubiquitous 
tissue expression [20,21]. However, expression of β2 and β3 isoforms in chondrocytes, in addition to 
the  β1 isoform, was surprising. The β2 isoform, also known as AMOG (adhesion molecule on 
glia) [37], is expressed in a number of tissues but mainly in neural tissues [38]. The β2 subunit is 
important for the development of the central nervous system  [37,39,40] and mice deficient for 
AMOG/β2 exhibit neuronal [41]. 
The  β3 isoform also appears to be expressed in human chondrocytes in situ  [29] and human 
chondrocyte-like cells (this study). The β isoforms are glycoproteins displaying branched 
oligosaccharides to the extracellular environment. Since glycoproteins have been implicated in cell 
recognition and cell signaling, it may be possible that multiple β isoforms allow chondrocytes to detect 
changes in their extracellular environment. The α subunit of Na
+, K
+-ATPase has long been known to 
bind various intracellular cytoskeletal proteins including ankyrin [42,43] and actin [44,45]. β subunit Int. J. Mol. Sci. 2012, 13 5027 
 
 
isoforms may play a role in the biogenesis of chondrocyte Na
+, K
+-ATPase or modulating the 
longevity and intracellular trafficking of Na
+, K
+-ATPase complexes [14]. 
3. Experimental Section 
3.1. Chemicals, Tissue Culture and Molecular Biology Kits 
Chemicals were purchased from Sigma/Aldrich (Poole, UK). Chemicals used in molecular biology 
experiments were molecular biology grade and those used in cell culture and gel electrophoresis/ 
Western blotting procedures were tissue culture and electrophoresis grade respectively. Fetal bovine 
serum was obtained from Life Sciences (Paisley, Scotland) and Sigma/Aldrich. Molecular biology kits 
were obtained from BioGene Ltd (Kimbolton, UK) and Advanced Biotechnologies (Epsom, UK). 
Electrophoresis reagents were obtained from Novex (San Diego, USA). Oligonucleotide primers were 
obtained from Genosys Biotechnologies (Cambridgeshire, UK) and Genset SA Europe (Paris, France) 
affiliated with Helena Biosciences (Sunderland, UK). Thin-walled PCR tubes were purchased from 
Perkin Elmer (Norwalk, USA). 
3.2. Human Tissues 
Samples of human brain and skeletal muscle were used as positive control tissues for western blot 
characterization of the monoclonal antibodies to the α1, α2,  α3 isoforms of the Na
+, K
+-ATPase. 
Tissues were obtained from the University Hospital of Universidad de La Laguna with local Ethics 
Committee approval. Plasma membrane enriched microsomes were prepared as described for C-20/A4 
cells below. 
3.3. Antibodies 
Well characterized non-commercial monoclonal and polyclonal antibodies to the α1, α2, α3, β1 and 
β2 subunits of the Na
+, K
+-ATPase were selected based on our previous observations and information 
available in the literature. The overriding priority in our selection procedure was suitability for use in 
human cells. The antibodies employed in this study and information and references pertaining to their 
specificity are shown in Table 2. Specific antibodies are currently available against three α (α1, α2 and 
α3) and two β isoforms (β1 and β2). Although polyclonal antibodies against the β3 subunit are also 
available, these are not suitable for studies on human cells as they only recognize the β3 subunit of rat 
and mouse [46]. Secondary antibodies used were previously pre-adsorbed with human serum proteins 
by the manufacturer. Rhodamine-conjugated anti-rabbit IgG (H + L) pre-adsorbed with human, mouse 
and rat serum proteins were purchased from Jackson ImmunoResearch laboratories Inc (PA, USA). 
Fluorescein-conjugated anti-mouse IgG was obtained from Dako Ltd., (Cambridge, UK). Alkaline 
phosphatase-conjugated anti-mouse and anti-rabbit-IgG was obtained from Sigma/Aldrich. Int. J. Mol. Sci. 2012, 13 5028 
 
 
Table 2. Isoform specific monoclonal and polyclonal antibodies employed in this study. 
Antibody Isoform  Working  Dilution Source  Reference 
mAb 9A7 (pan α monoclonal)  α isoforms  1:100  M. Takahashi   [47] 
α5 
§ (monoclonal)  α isoforms  Neat Supernatant  D.M. Fambrough and DSHB *   [48] 
α6F (monoclonal)  α1  Neat Supernatant  D.M. Fambrough and DSHB *   [49] 
α620 (polyclonal)  α1  1:100–1:200  M. Caplan   [50,51] 
McB2 (monoclonal)  α2 Neat  Supernatant  K.J. Sweadner   [52] 
McBX3 (monoclonal)  α3 Neat  Supernatant  K.J. Sweadner   [30,46] 
XVIF9G10 (monoclonal)  α3 Neat  Supernatant  K.J. Sweadner   [30,46] 
SpETb1 (polyclonal)  β1  1:200–1:400  P. Martín-Vasallo   [53] 
SpETb2 (polyclonal)  β2  1:200–1:400  P. Martín-Vasallo   [53] 
* The α5 and α6F monoclonal antibodies were developed by D. Fambrough were obtained from the 
Developmental Studies Hybridoma Bank (DSHB [54]) developed under the auspices of the NICHD and 
maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242, USA.  
§ The α5 monoclonal broadly recognizes Na
+, K
+-ATPase  α subunits of avian, mammalian and insect   
species. There are 4 known α isoforms and the designation “α5” does not indicate the existence of a fifth  
Na
+, K
+-ATPase α isoform. 
3.4. Human Chondrocyte Cell Line 
For all the experiments described a human chondrocyte-like cell line designated C-20/A4 was 
used  [55]. The cells were grown in 75 cm
3 flasks in Dulbecco’s modified Eagle’s medium with   
1000 mg glucose/L, L-glutamine, NaHCO3 and pyridoxine HCl (Sigma D-6046) supplemented with 
5% fetal calf serum (Gibco BRL 10108-157 or Sigma F-2442) and 1% antibiotic/antimycotic solution 
(Sigma A-5955) in a humidified incubator (95% air, 5% CO2). Cells from passages 12–24 were used in 
this study. In all experiments described, the cells were used when 95% confluent and 95% viable as 
determined by Trypan blue dye exclusion assays. The cells used in some immunological experiments 
were grown on poly-L-lysine coated slides. The morphology of the cells and the viability was   
not affected. 
3.5. Preparation of Plasma Membrane Enriched Microsomes  
C-20/A4 were lysed in a glass-teflon homogenizer using a homogenization buffer consisting of  
50 mM Tris-HCl, 1 mM ethylenediamine-tetraacetic acid (EDTA), 1 mM phenylmethylsulphonyl 
fluoride (PMSF), and 1 mg/mL of each of the protease inhibitors aprotinin, leupeptin and pepstatin  
(to prevent non-specific proteolytic degradation). The lysate was centrifuged at 100,000 g for 35 min 
to obtain a fraction enriched in plasma membranes. Protein assays were performed using a Bio-Rad kit. 
3.6. Gel Electrophoresis and Western Blotting 
C-20/A4 membranes were subjected to electrophoresis using pre-cast Novex NuPAGE™   
Bis-Tris-HCl buffered (pH 6.4) gels in a Novex X-CELL II™ unit. Assayed protein samples were 
diluted in 4× sample buffer (1.17 M sucrose, 563 mM Tris Base, 423 mM Tris HCl, 278 mM SDS, 
2.05 mM EDTA, 0.88 mM Serva Blue G250, 0.7 mM phenol red and ultrapure water). For the 
majority of experiments described 1.0 mm thick 4–12% gradient gels were used for optimum Int. J. Mol. Sci. 2012, 13 5029 
 
 
electrophoretic resolution. A MOPS (3-(N-morpholino) propane sulfonic acid) SDS (sodium dodecyl 
sulfate) running buffer was used. Electrophoretic transfer to nitrocellulose membranes (Hybond ECL, 
Amersham-Pharmacia, Bucks, UK) was performed in the same unit using a blot transfer module. The 
transfer buffer consisted of Bicine, Bis-Tris and EDTA. 
3.7. Cell Fixation and Immunolabeling  
C-20/A4 cells were allowed to attach to poly-L-lysine pre-coated slides (BDH, UK). Cells were 
fixed in ice-cold methanol for 10 min at −20 °C. After removal from the fixative the cells were washed 
once with PBS. Subsequently the cells were washed 3× with PBS. Non-specific binding was blocked 
by incubating the cells with PBS containing 10% normal goat serum (NGS; Sigma) for 1 h at room 
temperature. Primary α and β-isoform specific antibodies (see Table 2) were diluted in PBS containing 
1% NGS and incubated with C-20/A4 cells for 2 h at room temperature. The cells were then washed 
4× in PBS, and incubated with FITC-conjugated and TRITC-conjugated anti-mouse or anti-rabbit IgG 
(Sigma) in PBS containing 1% NGS (2 h at room temperature). The cells were finally washed 4× with 
PBS and mounted in mounting medium (Vectashield, Vector Laboratories Burlingame CA). In some 
immunocytochemical experiments, alkaline phosphatase- labeled anti-mouse and anti-rabbit secondary 
antibodies were used. For localization of alkaline phoshophatase activity Sigma Fast Red TR/Napthol 
AS-MX phosphate (4-chloro-2-methylbenzenediazonium/3-Hydroxy-2-naphtoic acid 2,4-dimethylanilide 
phosphate) tablets were used. 
3.8. Immunofluorescence Microscopy 
Chondrocytes probed with α and β isoform specific antibodies using procedures described above 
were examined using a Zeiss fluorescence microscope fitted with an oil immersion objective (100×) 
and a MC 100 SPOT 35 mm microscope camera with automatic exposure control. 
3.9. FACS Analysis 
C-20/A4 chondrocytes grown to confluence as monolayer cultures were removed from culture 
flasks by treatment with trypsin EDTA (Life Technologies, UK), washed three times with PBS and 
fixed in 3.7% neutral buffered paraformaldehyde (Sigma, UK) in PBS for 10 min at 37 °C. The cells 
were washed three times with PBS and aliquots of 10
−5 cells/100 mL PBS were placed into 1.5 mL 
eppendorf tubes, spun down (2000 rpm, 5 min) and the cell pellets were incubated with 100 mL 
aliquots of α subunit specific monoclonal antibodies (pan α, α6F, McB2 and McBX3; see Table 2 for 
dilutions used) at 4 °C overnight. Negative controls were incubated with 100 mL of a non-immune 
mouse IgG (DAKO, UK). Following three washes with PBS, the cells were incubated with 100 mL 
FITC-conjugated goat anti-mouse IgG diluted 1:100 (Sigma, UK) in PBS at 4 °C for 1 h in the dark. 
After three further washes in PBS, the cells were resuspended in 0.5 mL PBS and analyzed on a 
Becton-Dickinson FACScan. Plot profiles and histograms were generated using WinMDI flow 
cytometry software [31]. Statistical analysis was also performed using WinMDI. Int. J. Mol. Sci. 2012, 13 5030 
 
 
4. Conclusions 
Chondrocytes are routinely exposed to a variable ionic and osmotic environment in cartilage   
matrix. Maintaining an optimal Na
+:K
+ ratio is essential for intracellular homeostasis and for the 
synthesis of a mechanically resilient extracellular matrix. This study confirms that Na
+, K
+-ATPase in 
chondrocyte-like cells exists in a variety of isozyme combinations. Different combinations of α and β 
isoforms have been expressed in human and insect cell models and results suggest that experimental 
exchange of isoforms modifies pump kinetics (affinities for ions, ATP and ouabain) and functional 
properties of the enzyme complex (reviewed in  [14]). The existence of multiple forms of   
Na
+, K
+-ATPase in human chondrocytes in situ and the expression of the same isoforms in the 
immortalized human chondrocyte-like cells suggest that the C-20/A4 exposed to different extracellular 
environments, anti-inflammatory drugs, growth factors, hormones and cytokines. This approach would 
help determine the contribution of ion transport to cellular repair processes that may be initiated 
following extracellular matrix degradation in pathologies of articular cartilage. It would be premature 
to speculate upon any direct involvement of Na
+, K
+-ATPase in pathologies of articular cartilage.  
Na
+, K
+-ATPase and other transport systems may prove to be indirectly involved in the cellular 
adaptation to extracellular matrix changes that occur in arthritis.  
This study confirms previous observations in isolated bovine chondrocytes  [26] and human 
chondrocytes [29]  supporting a crucial role for Na
+, K
+-ATPase in chondrocyte homeostasis and 
cartilage maintenance. Now that the molecular composition of Na
+, K
+-ATPase and the relative 
abundance of its subunit isoforms’ expression is established, the next challenge is to evaluate the effect 
of cartilage specific anabolic growth factors and catabolic cytokines on the abundance and activity of 
Na
+, K
+-ATPase as a system and the expression of its subunit constituents. This objective will only be 
accomplished using a suitable cell-line instead of freshly isolated cells. The C-20/A4 cell-line is a 
convenient and easily accessible chondrocyte model, which can be grown under standard conditions in 
different laboratories and studied independently. 
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